Journal of Genetic Counseling

, Volume 17, Issue 1, pp 84–91 | Cite as

Emotional Reaction to Fragile X Premutation Carrier Tests Among Infertile Women

  • Lisa M. Pastore
  • Wendy L. Morris
  • Logan B. Karns
Original Research


Female fragile X premutation carriers are at ∼10-fold increased risk of premature ovarian failure (follicle stimulating hormone >40 mIU/mL, amenorrhea, age <40). A milder degree of premature ovarian aging (diminished ovarian reserve, where follicle stimulating hormone levels are typically 10–20 mIU/mL) results in infertility. Approximately 10% of fertility clinic patients have this diagnosis. A cohort of 20 women diagnosed with diminished ovarian reserve provided a blood specimen (confidential results), and completed structured questionnaires that assessed emotional reactions to potentially being a premutation carrier (pretest questionnaire, n = 20) and the posttest known carrier status (3 month follow-up questionnaire, n = 18 non-carriers). Responses were measured using 9-point scales, and analyzed with Fisher exact and Wilcoxon exact tests. While most participants did not view fragile X premutations as a serious medical condition, perceptions of seriousness were positively correlated with anger and regret about not knowing sooner of the potential association of these premutations with infertility. Overall, when women (pretest) imagined themselves as carriers, their self-esteem and Health Orientation Scale responses were unchanged with the exception of feeling more afraid (p = 0.004). Despite strongly wishing for negative test results, they were glad to know there might be a medical explanation for their infertility.


Diminished ovarian reserve Fragile X Genetic counseling Genetic screening FMR1 gene Emotions Infertility Female 



The Research & Development Committee of the School of Medicine at the University of Virginia provided funding for this study. We are grateful for the assistant of Teresa Camp (research assistant, informed consents), Heidi Flanagan (research nurse), Renata Ornelas (research nurse), Anna Wyse (research nurse), and Kelly Gurka (statistical assistance). We also thank the members of our research team that are not co-authors on this particular manuscript: Dr. Lawrence Silverman (UVa), Dr. Devereux N. Saller (UVa), and Dr. Christopher Williams (private practice).


  1. ACOG Committee on Genetics (2006). Screening for fragile X syndrome. Obstetrics & Gynecology, 107(6), 1483–1485.Google Scholar
  2. Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16(1), 97–104.PubMedCrossRefGoogle Scholar
  3. Anido, A., Carlson, L. M., Taft, L., & Sherman, S. (2005). Women’s attitudes toward testing for fragile X carrier status: A qualitative analysis. Journal of Genetic Counseling, 14(4), 295–306.PubMedCrossRefGoogle Scholar
  4. Braat, D. D., Smits, A. P., & Thomas, C. M. (1999). Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: A pilot study. American Journal of Medical Genetics, 83, 327–328.PubMedCrossRefGoogle Scholar
  5. Brown, W. T., Houck Jr., G. E., Ding, X., Zhong, N., Nolin, S., Glicksman, A., et al. (1996). Reverse mutations in the fragile X syndrome. American Journal of Medical Genetics, 64(2), 287–292.PubMedCrossRefGoogle Scholar
  6. Fisch, G. S., Snow, K., Thibodeau, S. N., Chalifaux, M., Holden, J. J., Nelson, D. L., et al. (1995). The fragile X premutation in carriers and its effect on mutation size in offspring. American Journal of Human Genetics, 56(5), 1147–1155.PubMedGoogle Scholar
  7. Greil, A. L. (1997). Infertility and psychological distress: A critical review of the literature. Social Science and Medicine, 45(11), 1679–1704.PubMedCrossRefGoogle Scholar
  8. Hagerman, P. J., & Hagerman, R. J. (2004). The fragile-X premutation: A maturing perspective. American Journal of Human Genetics, 74(5), 805–816 [erratum appears in am j hum genet. 2004 aug;75(2):352].PubMedCrossRefGoogle Scholar
  9. Imeson, M., & McMurray, A. (1996). Couples’ experiences of infertility: A phenomenological study. Journal of Advanced Nursing, 24(5), 1014–1022.PubMedCrossRefGoogle Scholar
  10. Levi, A. J., Raynault, M. F., Bergh, P. A., Drews, M. R., Miller, B. T., & Scott Jr., R. T. (2001). Reproductive outcome in patients with diminished ovarian reserve. Fertility & Sterility, 76(4), 666–669.CrossRefGoogle Scholar
  11. McConkie-Rosell, A., Abrams, L., Finucane, B., Cronister, A., Gane, L. W., Coffey, S. M., et al. (2007). Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling, in press.Google Scholar
  12. McConkie-Rosell, A., Spiridigliozzi, G. A., Iafolla, T., Tarleton, J., & Lachiewicz, A. M. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics, 68(1), 62–69.PubMedCrossRefGoogle Scholar
  13. McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2001). Longitudinal study of the carrier testing process for fragile X syndrome: Perceptions and coping. American Journal of Medical Genetics, 98, 37–45.PubMedCrossRefGoogle Scholar
  14. Murray, A., Webb, J., MacSweiney, F., Shipley, E. L., Morton, N. E., & Conway, G. S. (1999). Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in fraxa premutation women. Human Reproduction, 14(5), 1217–1218.PubMedCrossRefGoogle Scholar
  15. Nolin, S. L., Brown, W. T., Glicksman, A., Houck Jr., G. E., Gargano, A. D., Sullivan, A., et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72(2), 454–464.PubMedCrossRefGoogle Scholar
  16. Nolin, S. L., Lewis 3rd, F. A., Ye, L. L., Houck Jr., G. E., Glicksman, A. E., Limprasert, P., et al. (1996). Familial transmission of the FMR1 CGG repeat. American Journal of Human Genetics, 59(6), 1252–1261.PubMedGoogle Scholar
  17. Pastore, L. M., Karns, L. B., Pinkerton, J. V., Silverman, L. M., Williams, C. D., & Camp, T. R. (2006). Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. American Journal of Obstetrics and Gynecology, 194(3), 738–743.PubMedCrossRefGoogle Scholar
  18. Reyniers, E., Vits, L., De Boulle, K., Van Roy, B., Van Velzen, D., de Graaff, E., et al. (1993). The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genetics, 4(2), 143–146.PubMedCrossRefGoogle Scholar
  19. Rosenberg, M. (1986). Conceiving the self. Malabar, FL: Krieger.Google Scholar
  20. Scott Jr., R. T., Opsahl, M. S., Leonardi, M. R., Neall, G. S., Illions, E. H., & Navot, D. (1995). Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Human Reproduction, 10(7), 1706–1710.PubMedGoogle Scholar
  21. Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97, 189–194.PubMedCrossRefGoogle Scholar
  22. Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584–587.PubMedCrossRefGoogle Scholar
  23. Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7th ed.). Philadelphia: Lippincott Williams & Wilkins.Google Scholar
  24. Stephen, E. H., & Chandra, A. (2000). Use of infertility services in the United States: 1995. Family Planning Perspectives, 32(3), 132–137.PubMedCrossRefGoogle Scholar
  25. Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402–412.PubMedCrossRefGoogle Scholar
  26. Virginia NCHS Abridged-Race Population Estimates. Retrieved 03-21-2007, from
  27. Vits, L., De Boulle, K., Reyniers, E., Handig, I., Darby, J. K., Oostra, B., et al. (1994). Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Human Genetics, 94(5), 523–526.PubMedCrossRefGoogle Scholar
  28. Welt, C. K., Smith, P. C., & Taylor, A. E. (2004). Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology and Metabolism, 89(9), 4569–4574.PubMedCrossRefGoogle Scholar
  29. Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western Journal of Nursing Research, 19(1), 71–82.PubMedCrossRefGoogle Scholar
  30. Wooldridge, E. Q., & Murray, R. F. J. (1988). The health orientation scale: A measure of feelings about sickle cell trait. Social Biology, 35(1–2), 126–136.Google Scholar
  31. Wuensch, K. L. (2004). Nonparametric statistics. Retrieved 01-12-2005, from

Copyright information

© National Society of Genetic Counselors, Inc. 2007

Authors and Affiliations

  • Lisa M. Pastore
    • 1
    • 3
  • Wendy L. Morris
    • 2
  • Logan B. Karns
    • 1
  1. 1.Department of Obstetrics and Gynecology, School of MedicineUniversity of VirginiaCharlottesvilleUSA
  2. 2.Department of PsychologyMcDaniel CollegeWestminsterUSA
  3. 3.OB/GYN DepartmentUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations